Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million
Odyssey Health (OTCQB: ODYY) announced a multi-million-dollar, nine-year maintenance service contract for a commercial medical property, which the company says will create a stable, recurring revenue stream and support its transition to cash-generating operations.
The company also secured a financing facility of up to $25 million; an initial tranche of $500,000 will be used to advance Odyssey’s BreastCheck® sub-licensing program for a rapid, non-invasive breast screening test. Management described the deals as improving financial flexibility and enabling strategic commercialization initiatives.
Odyssey Health (OTCQB: ODYY) ha annunciato un contratto di manutenzione pluriennale, dal valore multimilionario, della durata di nove anni per una proprietà medicale commerciale, che l'azienda ritiene creerà un flusso di entrate stabile e ricorrente e sosterrà la sua transizione verso operazioni in grado di generare contanti.
L'azienda ha inoltre ottenuto una linea di finanziamento fino a 25 milioni di dollari; una prima tranche di 500.000 dollari sarà impiegata per avanzare il programma di sottolicenza BreastCheck® di Odyssey per un test di screening del seno rapido e non invasivo. La direzione ha descritto gli accordi come un miglioramento della flessibilità finanziaria e come abilitanti iniziative di commercializzazione strategica.
Odyssey Health (OTCQB: ODYY) anunció un contrato de servicio de mantenimiento multimillonario, de nueve años para una propiedad médica comercial, que la empresa afirma que generará un flujo de ingresos estable y recurrente y apoyará su transición hacia operaciones que generan efectivo.
La compañía también logró una facilidad de financiación de hasta 25 millones de dólares; una tranche inicial de 500,000 dólares se utilizará para avanzar el programa de sub-licencias BreastCheck® de Odyssey para una prueba de cribado mamario rápida y no invasiva. La dirección describió los acuerdos como una mejora de la flexibilidad financiera y como un impulso para iniciativas de comercialización estratégicas.
Odyssey Health (OTCQB: ODYY)는 상업용 의료 시설에 대한 다중 수백만 달러 규모의 9년간 유지보수 서비스 계약을 발표했으며, 회사는 이것이 안정적이고 재발하는 수익 흐름을 창출하고 현금 창출 운영으로의 전환을 지원할 것이라고 말합니다.
또한 회사는 최대 2,500만 달러의 금융 설비를 확보했습니다; 초기 50만 달러의 트랜치는 Odyssey의 BreastCheck® 하위 라이선스 프로그램을 빠르고 비침습적인 유방 선별 검사로 진전시키는 데 사용될 예정입니다. 경영진은 이 거래들이 재무 유연성을 개선하고 전략적 상용화 이니셔티브를 가능하게 한다고 설명했습니다.
Odyssey Health (OTCQB: ODYY) a annoncé un contrat de maintenance pluri-millions de dollars sur neuf ans pour une propriété médicale commerciale, que l'entreprise affirme générer une source de revenus stable et récurrente et soutenir sa transition vers des activités générant des liquidités.
L'entreprise a également obtenu une facilité de financement pouvant atteindre 25 millions de dollars; une tranche initiale de 500 000 dollars sera utilisée pour faire progresser le programme de sous-licence BreastCheck® d'Odyssey pour un test de dépistage rapide et non invasif du sein. La direction a décrit ces accords comme améliorant la flexibilité financière et permettant des initiatives de commercialisation stratégiques.
Odyssey Health (OTCQB: ODYY) gab einen Mehr-Millionen-Dollar-Wartungsvertrag über neun Jahre für eine kommerzielle medizinische Liegenschaft bekannt, von dem das Unternehmen sagt, dass er eine stabile, wiederkehrende Einnahmenquelle schafft und seinen Übergang zu operativen, geldschöpfenden Aktivitäten unterstützt.
Das Unternehmen hat außerdem eine Finanzierungsfazilität von bis zu 25 Millionen Dollar erhalten; eine erste Tranche von 500.000 Dollar wird genutzt, um Odyssey's BreastCheck®-Unterlizenzierungsprogramm für einen schnellen, nicht-invasiven Brustscreening-Test voranzutreiben. Das Management beschrieb die Vereinbarungen als eine Verbesserung der finanziellen Flexibilität und als Ermöglichung strategischer Kommerzialisierungsinitiativen.
Odyssey Health (OTCQB: ODYY) أعلنت عن عقد صيانة بقيمة عدة ملايين من الدولارات، لمدة تسع سنوات لعقار طبي تجاري، وتقول الشركة إنه سيخلق تدفقاً ثابتاً ومتكرراً من الإيرادات ويدعم تحولها إلى عمليات توليد النقد.
كما أمنت الشركة تسهيل تمويل يصل إلى 25 مليون دولار؛ سيتم استخدام الدُفعة الأولية قدرها 500,000 دولار لتقدم برنامج الترخيص الفرعي BreastCheck® لشركة Odyssey لاختبار فحص الثدي السريع وغير الجراحي. ووصف الإدارة هذه الاتفاقيات بأنها تعزز المرونة المالية وتمكن مبادرات التسويق الاستراتيجية.
- Financing facility up to $25 million secured
- Nine-year service contract established for commercial medical property
- Initial tranche of $500,000 allocated to BreastCheck sub-licensing
- Recurring revenue from long-term maintenance contract
- None.
Service agreement and financing facility supports strategic growth and commercialization initiatives
LAS VEGAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY), a medical device company focused on developing and commercializing life-saving medical solutions, today announced it has entered into a multi-million-dollar, nine-year maintenance service contract for a commercial medical property. The long-term agreement creates a stable, recurring revenue stream and marks a significant step in Odyssey’s ongoing transition toward sustainable, cash-generating operations.
The Company has secured a financing facility of up to
“This agreement delivers predictable monthly cash flow and underscores our commitment to building recurring, scalable revenue,” said Michael Redmond, President and CEO of Odyssey Health, Inc. “The financing facility further positions us to capitalize on growth opportunities across our diversified portfolio and drive long-term shareholder value.”
The new facility services contract and financing facility follow a series of strategic transactions that highlight Odyssey’s strengthening financial position and operational momentum. Most recently, Odyssey entered into a sub-licensing agreement for exclusive, worldwide rights to BreastCheck®, a rapid, non-invasive screening test for breast abnormalities.
About Odyssey Health, Inc.
Odyssey Health, Inc. (OTCQB: ODYY) is a medical technology company with a focus in the area of life- saving medical solutions. Odyssey’s corporate mission is to create, acquire and accumulate distinct assets, intellectual properties, and exceptional technologies that provide meaningful medical solutions The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, have a substantial market opportunity. Odyssey Medical Devices, Inc is a wholly owned subsidiary of Odyssey Health Inc.
For more information, visit www.odysseyhealthinc.com.
About BreastCheck®
BreastCheck®, a product of Davion Healthcare PLC, is a safe, accurate and low-cost, way to routinely monitor for breast abnormalities and is intended to be an adjunct to established procedures for the detection of breast disease, such as clinical breast examination and mammography. Abnormalities within the breast frequently produce additional breast heat. BreastCheck® averages temperature at three areas on each breast. By comparing the temperature of corresponding areas of one breast to the other and entering the results on the BreastCheck® Mobile App, results can be interpreted immediately.
The BreastCheck® test can be performed at home in approximately 15 minutes, providing immediate results that help identify potential breast abnormalities at an early stage. This innovative technology aligns with Odyssey’s mission to deliver accessible, life-saving diagnostic solutions that can meaningfully impact patient outcomes worldwide.
For more information about BreastCheck®, visit: https://www.odysseyhealthinc.com/breastcheck
Contact:
Investor Relations
Odyssey Health, Inc.
Email: info@odysseyhealthinc.com
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s beliefs and assumptions and information currently available. The words "believe," "expect," "anticipate," "intend," "estimate," "project" and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include, but are not limited to: the Company’s ability to successfully implement the facility service agreement; the Company’s ability to rely on predictable cash flows; the Company’s ability to utilize the financing facility to support strategic initiatives; the Company’s ability to capitalize on growth opportunities and drive long-term shareholder value; and the Company’s ability to advance the development and commercialization of the BreastCheck®; as well as other uncertainties described in our filings with the U.S. Securities and Exchange Commission. All information set forth is as of the date hereof unless otherwise indicated. You should consider these factors in evaluating the forward-looking statements.
FAQ
What did Odyssey Health (ODYY) announce on November 19, 2025 regarding new contracts?
How large is the financing facility Odyssey Health (ODYY) secured and what is the initial tranche?
What will the $500,000 initial tranche fund for Odyssey Health (ODYY)?
Does the nine-year maintenance contract affect Odyssey Health’s (ODYY) revenue model?
What rights does Odyssey have for BreastCheck after the sub-licensing agreement?
How did Odyssey’s management describe the impact of the new contract and financing on shareholders?
